Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001455244-10-000069)

Filing Details

Accession Number:: 0001455244-10-000069
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-17 13:00:00
Reporting Period:: 2010-03-11

Filing Date:: 2010-03-17
Accepted Time:: 2010-03-17 18:28:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
72444	Nabi Biopharmaceuticals	NABI	Biological Products, (No Disgnostic Substances) (2836)	591212264

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1459477	W. Matthew Kalnik	8610 Fernwood Road Bethesda MD 20817	Svp Strategic Plan. & Bus. Ops	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-03-11	1,125	$3.95	40,648	No	4	M	Direct
Common Stock	Disposition	2010-03-11	1,125	$5.95	39,523	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2010-03-11	1,125	$0.00	1,125	$3.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,625		2015-04-01	No	4	M	Direct

Footnotes

The acquisition and sale of 1,125 shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The Option will become exercisable in four equal annual installments. The first installment vested on April 1, 2009. The remaining installments vest on April 1, 2010, April 1, 2011 and April 1, 2012.